Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

Université de Montréal

$15,000.00

Market assessment for a novel instrument based on surface plasmon resonance

EF 2011-12

Résumé
A market assessment is necessary to establish the priorities that will dictate the next steps for the development of a novel Surface Plasmon Resonance (SPR) instrument. Our prototype SPR device is label-free, inexpensive, exhibits high sensitivity and selectivity and is suited for the analysis of biomarkers in crude biofluids. These achievements were the consequence of a novel SPR instrument design based on a dove prism, and a sensing chip technology based on micropatterned gold films and anti-fouling peptide surface chemistry. The prototype we have developed is portable and thus, is suited for point-of-measurement applications such as point-of-care diagnostics or on-site detection of contaminants or pathogens. The resolution of our portable SPR instrument rivals the one obtained with more expensive lab-based SPR instruments. Our sensing chip technology improves the sensitivity by more than a factor of 3 relative to other commercial sensing technologies, reducing error. In addition, our peptide monolayers prevent fouling of the sensing chip, and thus, false positive responses, which is necessary for point-of-care biomedical applications. The prototype is primarily geared to meet the increasing needs for fast and highly accessible medical diagnostics, in line with current policies that highlight the importance of rapid disease detection. Nonetheless, the detection technology is also applicable to further areas of commercial importance. This proposal aims at surveying the potential clients of a portable and highly sensitive SPR instrument. Identification of the industrial needs in analytical sciences will steer future developments. The completion of a SWOT analysis will compare the SPR method developed by the applicants with other existing technologies. Finally, the markets will be prioritized based on the strengths of the current technology. An entry point to the market will be identified and potential partners will be approached.
Programme
Idea to Innovation
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
428629-2011
Name nom
Masson, JeanFrancois
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
15000
Program id
I2IPJ
Program nane en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Market assessment for a novel instrument based on surface plasmon resonance
Keyword
NSERC
Application summary
A market assessment is necessary to establish the priorities that will dictate the next steps for the development of a novel Surface Plasmon Resonance (SPR) instrument. Our prototype SPR device is label-free, inexpensive, exhibits high sensitivity and selectivity and is suited for the analysis of biomarkers in crude biofluids. These achievements were the consequence of a novel SPR instrument design based on a dove prism, and a sensing chip technology based on micropatterned gold films and anti-fouling peptide surface chemistry. The prototype we have developed is portable and thus, is suited for point-of-measurement applications such as point-of-care diagnostics or on-site detection of contaminants or pathogens. The resolution of our portable SPR instrument rivals the one obtained with more expensive lab-based SPR instruments. Our sensing chip technology improves the sensitivity by more than a factor of 3 relative to other commercial sensing technologies, reducing error. In addition, our peptide monolayers prevent fouling of the sensing chip, and thus, false positive responses, which is necessary for point-of-care biomedical applications. The prototype is primarily geared to meet the increasing needs for fast and highly accessible medical diagnostics, in line with current policies that highlight the importance of rapid disease detection. Nonetheless, the detection technology is also applicable to further areas of commercial importance. This proposal aims at surveying the potential clients of a portable and highly sensitive SPR instrument. Identification of the industrial needs in analytical sciences will steer future developments. The completion of a SWOT analysis will compare the SPR method developed by the applicants with other existing technologies. Finally, the markets will be prioritized based on the strengths of the current technology. An entry point to the market will be identified and potential partners will be approached.